Liens UNIL

FR EN

Unisciences

Vous êtes ici: UNIL > Unisciences

Recherche
- Recherche
- Afficher les données
  de à

Service de pharmacie

La recherche avancée est accessible via Serval

Les publications peuvent être gérées en accédant à Serval via MyUnil

353 publications

... | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1990 | 1989 |

2015

Trace element monitoring in the ICU: quality and economic impact of a change in sampling practice.

Gagnon G., Voirol P., Soguel L., Boulat O., Berger M.M., 2015. Clinical Nutrition, 34 (3) pp. 422-427. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_B1C5BE899BA9]

Types of stereoselectivity in drug metabolism: a heuristic approach.

Testa B., 2015. Drug Metabolism Reviews, 47 (2) pp. 239-251.

[DOI][WoS][Pmid][serval:BIB_5C2555B88AA0]

2014

PHP121. Switching Patients With Primary Antibody Deficiencies to Home-Based Subcutaneous Immunoglobulin: Economic Evaluation of An Interprofessional Drug Therapy Management Program

Perraudin Clémence, Bourdin Aline, Berger Jérôme, Bugnon Olivier, 2014/11. dans Value in Health.

[DOI][serval:BIB_B9BC9B3328AA]

Development of ready-to-use cefuroxime syringes for use in ophthalmology

Fleury-Souverain Sandrine, Sadeghipour Farshid, Bonnabry Pascal, 2014/02. European Journal of Hospital Pharmacy, 21 (1) pp. 34-38.

[DOI][WoS][serval:BIB_6ADE3258BDCC]

Antiepileptika bei Frauen im gebärfähigen Alter und in der Schwangerschaft : Vergleich der Fachinformationen in Deutschland und der Schweiz mit dem aktuellen Wissensstand [Antiepileptics in women of childbearing age and during pregnancy : Comparison of specialized information with the current state of knowledge in Germany and Switzerland].

Winterfeld U., Gotta V., Rothuizen L.E., Panchaud A., Rossetti A.O., Buclin T., 2014. Der Nervenarzt, 85 (6) pp. 738-746. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_72BDC14B7721]

Aérosol-doseurs : un casse tête dans la détermination du contenu

Martignoni S., Hafen G., Pannatier A., Di Paolo E.R., 2014. PharmaJournal 10 pp. 5-6.

[serval:BIB_9F2CC056BA0C]

Discharge plan for patient with heart failure: it is worth to have a clinical pharmacist in the team

Nachar C., Voirol P., Sadeghipour F., Lamy O., Garnier A., 2014. dans European and Swiss congress of Internal Medicine 2014. Peer-reviewed.

[URN][serval:BIB_885FA0CEE21C]

Médicaments, grossesse et allaitement

Panchaud Alice, Berger Jérôme, Bugnon Olivier, 2014. pp. 23-25 dans BabyGuide – Le Manuel officiel Suisse, BabyGuide.

[serval:BIB_B3E8A046842B]

Passive lipoidal diffusion and carrier-mediated cell uptake are both important mechanisms of membrane permeation in drug disposition.

Smith D., Artursson P., Avdeef A., Di L., Ecker G.F., Faller B., Houston J.B., Kansy M., Kerns E.H., Krämer S.D. et al., 2014. Molecular Pharmaceutics, 11 (6) pp. 1727-1738. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_3E711CEC2DDF]

Qualitative analysis of barriers and facilitators encountered by HIV patients in an ART adherence programme.

Krummenacher I., Spencer B., Du Pasquier S., Bugnon O., Cavassini M., Schneider M.P., 2014. International Journal of Clinical Pharmacy, 36 (4) pp. 716-724. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_AD811818BEB0]

Small molecules as exemplars of emergent properties and diversification into the 'adjacent possible'.

Testa B., Vistoli G., Pedretti A., 2014. Chemistry and Biodiversity, 11 (9) pp. 1309-1329. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_3007663E9832]

Vade-Mecum de Pédiatrie, 4e édition.

Gehri M., Laubscher B., Di Paolo E.R., Roth-Kleiner M., Joseph J.M., Mazouni S.M., 2014. 450, BabyGuide.

[serval:BIB_0EF66C768B2B]

2013

Validation of a once-a-week set up for an automated compounder device for parenteral nutrition solutions

Bouchoud Lucie, Sadeghipour Farshid, Fleury-Souverain Sandrine, Bonnabry Pascal, 2013/08. European Journal of Hospital Pharmacy, 20 (4) pp. 236-240.

[DOI][WoS][serval:BIB_F6F7434A0DA9]

In vitro compatibility of various cardioactive drugs during simulated Y-site administration

Humbert-Delaloye Valia, Berger-Gryllaki Markoulina, Voirol Pierre, Gattlen Laurent, Pannatier André, 2013/04. European Journal of Hospital Pharmacy, 20 (2) pp. 110-116.

[DOI][WoS][serval:BIB_2E51E536414C]

Adherence to antiretroviral treatment decreases during postpartum compared to pregnancy: a longitudinal electronic monitoring study.

Gertsch A., Michel O., Locatelli I., Bugnon O., Rickenbach M., Cavassini M., Schneider M.P., 2013. AIDS Patient Care and STDs, 27 (4) pp. 208-210.

[DOI][WoS][Pmid][serval:BIB_48F1FB2D8EA3]

Albuterol delivery in an in vitro pediatric ventilator lung model: comparison of jet, ultrasonic, and mesh nebulizers.

Sidler-Moix A.L., Dolci U., Berger-Gryllaki M., Pannatier A., Cotting J., Di Paolo E.R., 2013. Pediatric Critical Care Medicine, 14 (2) pp. e98.

[DOI][WoS][Pmid][serval:BIB_02C34D2A1679]

Aérosol-doseurs : un casse tête dans la détermination du contenu.

Martignoni S., Hafen G, Pannatier A, Di Paolo E.R., 2013. Paediatrica, 24 (5) pp. 48-50.

[serval:BIB_8F025811773B]

Capsaicin mimics mechanical load-induced intracellular signaling events: involvement of TRPV1-mediated calcium signaling in induction of skeletal muscle hypertrophy.

Ito N., Ruegg U.T., Kudo A., Miyagoe-Suzuki Y., Takeda S., 2013. Channels, 7 (3) pp. 221-224.

[URN][DOI][WoS][Pmid][serval:BIB_3536D034BF52]

Cyberhealth serving to support individual intake of medication.

Schneider M.P., Gertsch A., Bugnon O., 2013. Swiss Medical Weekly, 143 pp. w13827.

[URN][DOI][WoS][Pmid][serval:BIB_850494CCEF5B]

Design, synthesis, and biological and crystallographic evaluation of novel inhibitors of Plasmodium falciparum enoyl-ACP-reductase (PfFabI).

Belluti F., Perozzo R., Lauciello L., Colizzi F., Kostrewa D., Bisi A., Gobbi S., Rampa A., Bolognesi M.L., Recanatini M. et al., 2013. Journal of Medicinal Chemistry, 56 (19) pp. 7516-7526.

[DOI][WoS][Pmid][serval:BIB_EB1C3E999AD0]

Evolving Trends in the Costs Associated With Hospital Use of Immunosuppressive Drugs.

Perrottet N., Aubert V., Venetz J.P., Ugolini E., Matter M., Pannatier A., Pascual M., 2013. Transplantation, 95 (5) pp. e24-e25.

[DOI][WoS][Pmid][serval:BIB_DB6B15EEC4D0]

Exploring the space of histidine containing dipeptides in search of novel efficient RCS sequestering agents.

Vistoli G., De Maddis D., Straniero V., Pedretti A., Pallavicini M., Valoti E., Carini M., Testa B., Aldini G., 2013. European Journal of Medicinal Chemistry, 66 pp. 153-160. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_F0ED3342AF38]

Expression, purification and biochemical characterization of recombinant Ca-dependent protein kinase 2 of the malaria parasite Plasmodium falciparum.

Lauciello L., Kappes B., Scapozza L., Perozzo R., 2013. Protein Expression and Purification, 90 (2) pp. 170-177. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_324CB2C5616C]

Fate of TLR-1/TLR-2 agonist functionalised pDNA nanoparticles upon deposition at the human bronchial epithelium in vitro.

Heuking S., Rothen-Rutishauser B., Raemy D.O., Gehr P., Borchard G., 2013. Journal of Nanobiotechnology, 11 (1) p. 29.

[URN][DOI][WoS][Pmid][serval:BIB_73BFD3A56D07]

Impact of Antibiotic Use on Carbapenem Resistance in Pseudomonas aeruginosa: Is There a Role for Antibiotic Diversity?

Plüss-Suard C., Pannatier A., Kronenberg A., Mühlemann K., Zanetti G., 2013. Antimicrobial Agents and Chemotherapy, 57 (4) pp. 1709-1713.

[DOI][WoS][Pmid][serval:BIB_16DF5BC2F5E8]

Organic Stereochemistry. Part 1. Symmetry Elements and Operations, Classification of Stereoisomers

Testa B., Vistoli G., Pedretti A., 2013. Helvetica Chimica Acta, 96 (1) pp. 4-30.

[DOI][WoS][serval:BIB_4C880EE3F066]

Pediatric drug-related problems: a multicenter study in four French-speaking countries.

Prot-Labarthe S., Di Paolo E.R., Lavoie A., Quennery S., Bussières J.F., Brion F., Bourdon O., 2013. International Journal of Clinical Pharmacy, 35 (2) pp. 251-259.

[DOI][WoS][Pmid][serval:BIB_E1BFD33338C3]

Phthalates in the NICU: Is it safe?

Fischer C.J., Bickle Graz M., Muehlethaler V., Palmero D., Tolsa J.F., 2013. Journal of Paediatrics and Child Health, 49 (9) pp. E413-E419.

[DOI][WoS][Pmid][serval:BIB_7820CFF74C46]

Remplissage semi-automatique des seringues prêtes-à-l'emploi

Sadeghipour F, Bonnabry P, 2013. Le moniteur hospitalier, 11 (260) pp. 14-17.

[serval:BIB_C5E1A6B11E8F]

Simulations in Evolution. III. Randomness as a Generator of Opportunities.

Testa B., Bojarski A.J., Mordalski S., 2013. Chemistry and Biodiversity, 10 (1) pp. 62-72.

[DOI][WoS][Pmid][serval:BIB_AF2B9EA19FEC]

Stress ulcer prophylaxis in non-critically ill patients: a prospective evaluation of current practice in a general surgery department.

Bez C., Perrottet N., Zingg T., Leung Ki E.L., Demartines N., Pannatier A., 2013. Journal of Evaluation in Clinical Practice, 19 (2) pp. 374-378.

[DOI][WoS][Pmid][serval:BIB_F45B163EE406]

Temporal variability of antibiotics fluxes in wastewater and contribution from hospitals.

Coutu S., Rossi L., Barry D.A., Rudaz S., Vernaz N., 2013. Plos One, 8 (1) pp. e53592.

[URN][DOI][WoS][Pmid][serval:BIB_37A31F8ED2F6]

Weed or wheel! FMRI, behavioural, and toxicological investigations of how cannabis smoking affects skills necessary for driving.

Battistella G., Fornari E., Thomas A., Mall J.F., Chtioui H., Appenzeller M., Annoni J.M., Favrat B., Maeder P., Giroud C., 2013/01. Plos One, 8 (1) pp. e52545. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_EF6F5D1419B9]

2012

A highly sensitive LC-tandem MS assay for the measurement in plasma and in urine of salbutamol administered by nebulization during mechanical ventilation in healthy volunteers.

Sidler-Moix A.L., Mercier T., Decosterd L.A., Di Paolo E.R., Berger-Gryllaki M., Cotting J., Pannatier A., 2012. Biomedical Chromatography : BMC, 26 (5) pp. 672-680. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_C0AEA0A28D92]

Changes in the use of broad-spectrum antibiotics after cefepime shortage: a time series analysis.

Plüss-Suard Catherine, Pannatier André, Ruffieux Christiane, Kronenberg Andreas, Mühlemann Katrin, Zanetti Giorgio, 2012. Antimicrobial Agents and Chemotherapy, 56 (2) pp. 989-994. Peer-reviewed.

[DOI][Pmid][serval:BIB_D1D1EFFA60DA]

Drug utilisation in a neonatal intensive care unit of a swiss university hospital

Palmero D., Di Paolo E.R., Tolsa J.F., Pannatier A., 2012. p. 209 dans 40th International Symposium on Clinical Pharmacy (ESCP), Clinical Pharmacy: Connecting Care and Outcomes, International Journal of Clinical Pharmacy.

[URN][WoS][serval:BIB_EC80AD40E464]

Evaluation of decontamination efficacy of cleaning solutions on stainless steel and glass surfaces contaminated by 10 antineoplastic agents

Queruau Lamerie T., Nussbaumer S., Décaudin B., Fleury-Souverain S., Goossens J.F., Bonnabry P., Odou P., 2012. Annals of Occupational Hygiene, 57 (4) pp. 456-469.

[URN][DOI][WoS][Pmid][serval:BIB_6DE4FFBE17B0]

Five-year evolution of drug prescribing in a university adult intensive care unit.

Carron C., Voirol P., Eggimann P., Pannatier A., Chioléro R., Wasserfallen J.B., 2012. Applied Health Economics and Health Policy, 10 (5) pp. 355-358. Peer-reviewed.

[DOI][Pmid][serval:BIB_D0F2D4E3DCA9]

Hypertriglyceridemia: a potential side effect of propofol sedation in critical illness.

Devaud J.C., Berger M.M., Pannatier A., Marques-Vidal P., Tappy L., Rodondi N., Chiolero R., Voirol P., 2012. Intensive Care Medicine, 38 (12) pp. 1990-1998. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_B1DD78955C87]

Hépatite C : avancées thérapeutiques

Schneider M.P., Genre N., Reymermier M., Bugnon O., Moradpour D., 2012. PharmaJournal, 150 (24) pp. 5-9.

[serval:BIB_50ECEDCD25FD]

In vitro compatibility of remifentanil hydrochloride and sufentanil citrate with selected drugs

Humbert-Delaloye V., Berger M., Voirol P., Pannatier A., 2012. European Journal of Hospital Pharmacy-Science and Practice, 19 (1) pp. 57-64.

[DOI][WoS][serval:BIB_715D6BBB51F4]

Outpatient prescription writing quality in a paediatric general hospital

Di Paolo E.R., Ruchet L., Gehri M., Lutz N., Fanconi S., Pannatier A., 2012. p. 249 dans 40th International Symposium on Clinical Pharmacy (ESCP), Clinical Pharmacy: Connecting Care and Outcomes, International Journal of Clinical Pharmacy.

[URN][WoS][serval:BIB_BB97692ACB9E]

Outpatient prescriptions practice and writing quality in a paediatric university hospital.

Di Paolo E., Gehri M., Ouedraogo-Ruchet L., Sibailly G., Lutz N., Pannatier A., 2012. Swiss Medical Weekly, 142 p. 0.

[URN][DOI][WoS][Pmid][serval:BIB_7BEF306456FC]

Perfusion-CT guided intravenous thrombolysis in patients with unknown-onset stroke: a randomized, double-blind, placebo-controlled, pilot feasibility trial.

Michel P., Ntaios G., Reichhart M., Schindler C., Bogousslavsky J., Maeder P., Meuli R., Wintermark M., 2012. Neuroradiology, 54 (6) pp. 579-588. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_272FAAEC45BE]

Predicting the physicochemical profile of diastereoisomeric histidine-containing dipeptides by property space analysis.

Vistoli G., Straniero V., Pedretti A., Fumagalli L., Bolchi C., Pallavicini M., Valoti E., Testa B., 2012. Chirality, 24 (7) pp. 566-576.

[DOI][WoS][Pmid][serval:BIB_DEA543E8ED1B]

Quels sont les dangers liés à l'utilisation de suppositoires à base d'huiles essentielleschez les petits enfants?

Pellaud N., Hafen G., Di Paolo E.R., Pannatier A., 2012. Paediatrica, 23 (4) pp. 35-36.

[URN][serval:BIB_F90BFF06958D]

Quels sont les dangers liés à l’utilisation de suppositoires à base d’huiles essentielles chez les petits enfants?

Di Paolo E.R., Pannatier A., 2012. Paediatrica, 23 (4) p. 35.

[serval:BIB_258E9FF14F9D]

Reactions and enzymes in the metabolism of drugs and other xenobiotics.

Testa B., Pedretti A., Vistoli G., 2012. Drug Discovery Today, 17 (11-12) pp. 549-560.

[DOI][WoS][Pmid][serval:BIB_EA7B63B171FE]

Screening of the inhibitory effect of xenobiotics on alcohol metabolism using S9 rat liver fractions.

Dias C., Testa B., Soveral G., Dias M., Constantino L., 2012. Toxicology in Vitro, 26 (7) pp. 1177-1180.

[DOI][WoS][Pmid][serval:BIB_E03DBD7DA665]

The hospital pharmacist: an important contributor to improved patient safety in the hospital.

Berthouzoz S., Berger L., Bonnabry P., Pannatier A., 2012. Chimia, 66 (5) pp. 300-303.

[DOI][WoS][Pmid][serval:BIB_5E4457C946A7]

To Monty Kier, a friendly tribute.

Testa B., 2012. Current Computer-aided Drug Design, 8 (2) pp. 85-86.

[WoS][Pmid][serval:BIB_4CBF0F19D612]

Urocortins improve dystrophic skeletal muscle structure and function through both PKA- and Epac-dependent pathways.

Reutenauer-Patte J., Boittin F.X., Patthey-Vuadens O., Ruegg U.T., Dorchies O.M., 2012. American Journal of Pathology, 180 (2) pp. 749-762.

[DOI][WoS][Pmid][serval:BIB_8E75A86730A0]

Wipe sampling procedure coupled to LC-MS/MS analysis for the simultaneous determination of 10 cytotoxic drugs on different surfaces.

Nussbaumer S., Geiser L., Sadeghipour F., Hochstrasser D., Bonnabry P., Veuthey J.L., Fleury-Souverain S., 2012. Analytical and Bioanalytical Chemistry, 402 (8) pp. 2499-2509.

[DOI][WoS][Pmid][serval:BIB_6039705663DF]

2011

Traitement et prophylaxie de la Maladie ThromboEmbolique Veineuse (MTEV)

Centre hospitalier universitaire vaudois, Policlinique médicale universitaire (Lausanne) , 2011/05. 2 p..

[URN][serval:BIB_EFE579EC6162]

Chemodiversity and molecular plasticity: recognition processes as explored by property spaces.

Vistoli G., Pedretti A., Testa B., 2011. Future Medicinal Chemistry, 3 (8) pp. 995-1010.

[DOI][WoS][Pmid][serval:BIB_C75E133F4199]

Clinical pharmacy in Switzerland: a big step forward

Voirol P., Zelger G., Schaad N., 2011. EJHP Practice, 17 (3) p. 60.

[WoS][serval:BIB_7283E31AB769]

Decision-support tools to manage drug incompatibilities: evaluation by nurses

Kaestli L.Z., Gschwind L., De Giorgi I., Guegueniat-Dupessey C., Fonzo-Christe C., Bonnabry P., 2011. p. 331 dans 39th ESCP (European Society of Clinical Pharmacy) European Symposium on Clinical Pharmacy and 13th SFPC (Société Française de Pharmacie Clinique) Congress: Clinical Pharmacy at the Front line of Innovations, International Journal of Clinical Pharmacy.

[WoS][serval:BIB_5A50E2697909]

Development of a method to investigate the hydrolysis of xenobiotic esters by a Mycobacterium smegmatis homogenate.

Valente E., Simões M.F., Testa B., Constantino L., 2011. Journal of Microbiological Methods, 85 (2) pp. 98-102.

[DOI][WoS][Pmid][serval:BIB_1A13AF20A647]

Hospital antibiotic consumption in Switzerland: comparison of a multicultural country with Europe.

Plüss-Suard C., Pannatier A., Kronenberg A., Mühlemann K., Zanetti G., 2011. Journal of Hospital Infection, 79 (2) pp. 166-171.

[DOI][WoS][Pmid][serval:BIB_DF674E4E4CBA]

Lipophilicity and its relationship with passive drug permeation.

Liu X., Testa B., Fahr A., 2011. Pharmaceutical Research, 28 (5) pp. 962-977.

[DOI][WoS][Pmid][serval:BIB_CA715AD71154]

Medicines manufacturing in hospital: from empirical craftsmanship to risk management

Pannatier A., 2011. EJHP Practice, 17 (1) p. 12.

[WoS][serval:BIB_D1C5BC657E4B]

Pharmaceutical care in an inpatient pediatric intensive care unit: an international multicentric study

Prot-Labarthe S., Di Paolo E., Lavoie A., Quennery S., Bussieres J.F., Brion F., Bourdon O., 2011. pp. 413-414 dans 39th ESCP (European Society of Clinical Pharmacy) European Symposium on Clinical Pharmacy and 13th SFPC (Société Française de Pharmacie Clinique) Congress: Clinical Pharmacy at the Front line of Innovations, International Journal of Clinical Pharmacy.

[WoS][serval:BIB_9AD9F079606E]

Stress ulcer prophylaxis in non-critically ill patients: a prospective evaluation of current practice in a general surgery department

Zingg T., Bez C., Perrottet N., Leung Ki E.L., Pannatier A., Demartines N., 2011. p. 7 dans 98th Annual Congress of the Swiss Society of Surgery, British Journal of Surgery. Peer-reviewed.

[WoS][serval:BIB_A89DAFAF7479]

Stress ulcer prophylaxis in non-critically ill patients: a prospective evaluation of the practice in a surgical ward

Perrottet N., Bez C., Zingg T., Leung Ki E.L., Demartines N., Pannatier A., 2011. p. 435 dans 39th ESCP (European Society of Clinical Pharmacy) European Symposium on Clinical Pharmacy and 13th SFPC (Société Française de Pharmacie Clinique) Congress: Clinical Pharmacy at the Front line of Innovations, International Journal of Clinical Pharmacy.

[WoS][serval:BIB_DA42F7C49330]

Substance P-induced skin inflammation is not modulated by a single dose of sitagliptin in human volunteers.

Grouzmann E., Bigliardi P., Appenzeller M., Pannatier A., Buclin T., 2011. Biological Chemistry, 392 (3) pp. 217-221.

[DOI][WoS][Pmid][serval:BIB_DE9CEF3B5B9F]

2010

Recombinant factor VIIa for intractable life-threatening bleeding in patients with circulatory assist devices.

Schneider A.G., Perez M.H., Tozzi P., Voirol P., Schoettker P., Angelillo-Scherrer A., Cotting J., Von Segesser L., Eggimann P., 2010/09. Intensive care medicine, 36 (9) pp. 1620-1621. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_98A4B780B011]

Relationship between drug-related problems and health outcomes: a cross-sectional study among cardiovascular patients

Niquille Anne, Bugnon Olivier, 2010/08. Pharmacy World & Science, 32 (4) pp. 512-519.

[DOI][WoS][Pmid][serval:BIB_90E97B4FD84D]

Blunting the response to endotoxin in healthy subjects: effects of various doses of intravenous fish oil.

Pittet Y.K., Berger M.M., Pluess T.T., Voirol P., Revelly J.P., Tappy L., Chioléro R.L., 2010/02. Intensive care medicine, 36 (2) pp. 289-295. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_22A6580B8935]

Changes in the use of broad-spectrum antibiotics after withdrawal of cefepime from the market: an interrupted time series analysis

Pluess-Suard Catherine, Pannatier Andre, Zanetti Giorgio, 2010. p. 274 dans ESCP-GSASA 38th symposium on clinical pharmacy 30 years of clinical pharmacy, a bright future ahead, Pharmacy World and Science. Peer-reviewed.

[WoS][serval:BIB_98274D1B3371]

Concomitant administration of intravenous drugs in the ICU: evaluation of physico-chemical compatibilities

Humbert-Delaloye V., Voirol P., Gattlen L., Berger L., Pannatier A., 2010. pp. 224-225 dans ESCP-GSASA 38th symposium on clinical pharmacy 30 years of clinical pharmacy; a bright future ahead., Pharmacy World and Science. Peer-reviewed.

[WoS][serval:BIB_A4DE331851C5]

Evaluation of the inhalation technique in asthmatic children visiting a specialised outpatient clinic

Breguet C., Di Paolo Ermindo R., Verga J., Gehri M., Pannatier A., 2010. p. 303 dans ESCP-GSASA 38th symposium on clinical pharmacy 30 years of clinical pharmacy, a bright future ahead, Pharmacy World and Science. Peer-reviewed.

[WoS][serval:BIB_D45A4A0F04D5]

Five-year evolution of drug prescribing in a university adult intensive care unit

Voirol P., Eggimann P., Carron C., Pannatier A., Chiolero R., Wasserfallen J.B., 2010. pp. P473 dans 30th International Symposium on Intensive Care and Emergency Medicine, Critical Care. Peer-reviewed.

[DOI][serval:BIB_0494CF74A196]

Ganciclovir exposure under a 450mg daily dosage of valganciclovir for cytomegalovirus prevention in kidney transplantation: a prospective study.

Manuel O., Pascual M., Perrottet N., Lamoth F., Venetz J.P., Decosterd L.A., Buclin T., Meylan P.R., 2010. Clinical Transplantation, 24 (6) pp. 794-800.

[DOI][WoS][Pmid][serval:BIB_4C94E197C48C]

Homology modeling and metabolism prediction of human carboxylesterase-2 using docking analyses by GriDock: a parallelized tool based on AutoDock 4.0.

Vistoli Giulio, Pedretti Alessandro, Mazzolari Angelica, Testa Bernard, 2010. Journal of Computer-aided Molecular Design, 24 (9) pp. 771-787.

[DOI][WoS][Pmid][serval:BIB_3CB21BB7648C]

Impact of chlorhexidine-impregnated sponges on catheter-related infections rate

Eggimann P., Joseph C., Thevenin M.J., Voirol P., Bellini C., Pagani J.L., Revelly J.P., 2010. pp. S128 dans 23rd Annual Meeting of the European Society of Intensive Care Medicine, Intensive Care Medicine. Peer-reviewed.

[WoS][serval:BIB_AB126A200628]

In silico prediction of human carboxylesterase-1 (hCES1) metabolism combining docking analyses and MD simulations.

Vistoli G., Pedretti A., Mazzolari A., Testa B., 2010. Bioorganic and Medicinal Chemistry, 18 (1) pp. 320-329. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_15088975F7F9]

Inpatient diabetes care in a Swiss multi-site hospital: is there room for improvement?

Zaugg C., Devaud J.C., Beney J., 2010. pp. 237-238 dans ESCP-GSASA 38th symposium on clinical pharmacy 30 years of clinical pharmacy; a bright future ahead, Pharmacy World and Science.

[WoS][serval:BIB_90137D7E08E8]

Qualitative structure-metabolism relationships in the hydrolysis of carbamates.

Vacondio F., Silva C., Mor M., Testa B., 2010. Drug Metabolism Reviews, 42 (4) pp. 551-589.

[DOI][WoS][Pmid][serval:BIB_F857DC56B9FA]

Risk and pharmacoeconomic analyses of the injectable medication process in the paediatric and neonatal intensive care units

De Giorgi I., Fonzo-Christe C., Cingria L., Caredda B., Meyer V., Pfister R.E., Bonnabry P., 2010. International Journal For Quality In Health Care : Journal of the International Society For Quality In Health Care, 22 (3) pp. 170-178.

[URN][DOI][WoS][Pmid][serval:BIB_0E8AC1007E27]

Risk factors for hypertriglyceridemia in the intensive care unit: an exploratory study

Devaud Jean-Christophe, Voirol Pierre, Marques-Vidal Pedro Manuel, Tappy Luc, Rodondi Nicolas, Chioléro René, Berger Mette M., Pannatier André, 2010. pp. S197 dans 30th International Symposium on Intensive Care and Emergency Medicine, Brussels, Belgium. 9-12 March 2010, Critical Care. Peer-reviewed.

[DOI][serval:BIB_EEE417C125CA]

Variable viral clearance despite adequate ganciclovir plasma levels during valganciclovir treatment for cytomegalovirus disease in D+/R- transplant recipients.

Perrottet Nancy, Manuel Oriol, Lamoth Frederic, Venetz Jean-Pierre, Sahli Roland, Decosterd Laurent A., Buclin Thierry, Pascual Manuel, Meylan Pascal, 2010. BMC Infectious Diseases, 10 p. 2.

[URN][DOI][WoS][Pmid][serval:BIB_1123642915A2]

2009

Prodrugs: bridging pharmacodynamic/pharmacokinetic gaps.

Testa B., 2009/06. Current opinion in chemical biology, 13 (3) pp. 338-344. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_CC6C6C70B498]

Adherence: a review of education, research, practice and policy in Switzerland.

Schneider Marie P., Krummenacher Isabelle, Figueiredo Hugo, Marquis Julien, Bugnon Olivier, 2009/04. Pharmacy practice, 7 (2) pp. 63-73. Peer-reviewed.

[URN][Pmid][serval:BIB_B08DC0CDB46B]

Atomic diversity, molecular diversity, and chemical diversity: the concept of chemodiversity.

Testa B., Vistoli G., Pedretti A., Bojarski A.J., 2009. Chemistry & Biodiversity, 6 (8) pp. 1145-1151.

[DOI][WoS][Pmid][serval:BIB_C1FEB34723E0]

Dispersal (Entropy) and Recognition (Information) as Foundations of Emergence and Dissolvence

Testa Bernard, 2009. Entropy, 11 (4) pp. 993-1000.

[DOI][WoS][serval:BIB_B8B22EB3245E]

Drug metabolism for the perplexed medicinal chemist.

Testa Bernard, 2009. Chemistry & Biodiversity, 6 (11) pp. 2055-2070.

[DOI][WoS][Pmid][serval:BIB_A552215F9E2F]

Formation et recherche en pharmacie hospitalière et communautaire – état des lieux et perspectives en Suisse romande

Pannatier André, Bugnon Olivier, Csajka Chantal, Bonnabry Pascal, 2009. Pharmactuel, 42 (Suppl. 1) pp. 53-61. Peer-reviewed.

[serval:BIB_AE234F1ABC0F]

Ganciclovir exposure under a 450 mg daily dosage of valganciclovir for cytomegalovirus prevention in kidney transplant recipients: a prospective study : P125

Manuel O., Pascual M., Perrottet N., Lamoth F., Venetz J.P., Decosterd L., Buclin T., Meylan P., 2009. pp. 32S-33S dans Joint Annual Congress of the Swiss Society for Allergology and Immunology and the Swiss Society for Infectious Diseases, Swiss Medical Weekly. Peer-reviewed.

[WoS][serval:BIB_80EADAB09A91]

Ganciclovir Exposure under a 450 mg Daily Dosage of Valganciclovir for the Prevention of Cytomegalovirus Disease in Kidney Transplant Recipients.

Manuel Oriol, Pascual Manuel, Perrottet Nancy, Lamoth Frederic, Venetz Jean-Pierre, Decosterd Laurent, Buclin Thierry, Meylan Pascal R., 2009. p. 249 dans 9th Joint Meeting of the American Society of Transplant Surgeon and of the American Society of Transplantation, American Journal of Transplantation. Peer-reviewed.

[WoS][serval:BIB_18DA47E61C5B]

Impact of a computerized physician order entry system on compliance with prescription accuracy requirements.

Mir C., Gadri A., Zelger G.L., Pichon R., Pannatier A., 2009. Pharmacy World and Science, 31 (5) pp. 596-602.

[DOI][WoS][Pmid][serval:BIB_2F310EFDCA1F]

Influence of ionization state on the activation of temocapril by hCES1: a molecular-dynamics study.

Vistoli Giulio, Pedretti Alessandro, Mazzolari Angelica, Bolchi Cristiano, Testa Bernard, 2009. Chemistry & Biodiversity, 6 (11) pp. 2092-2100.

[DOI][WoS][Pmid][serval:BIB_8F7895F1DA48]

Partition coefficient and molecular flexibility: the concept of lipophilicity space.

Vistoli G., Pedretti A., Testa B., 2009. Chemistry & Biodiversity, 6 (8) pp. 1152-1169.

[DOI][WoS][Pmid][serval:BIB_AB8B460889A5]

Population pharmacokinetics of ganciclovir in solid-organ transplant recipients receiving oral valganciclovir.

Perrottet N., Csajka C., Pascual M., Manuel O., Lamoth F., Meylan P., Aubert J.D., Venetz J.P., Soccal P., Decosterd L.A. et al., 2009. Antimicrobial agents and chemotherapy, 53 (7) pp. 3017-23.

[DOI][WoS][Pmid][serval:BIB_6BCA0E0A0A40]

The biochemistry of drug metabolism--an introduction: part 5. Metabolism and bioactivity.

Testa B., Krämer S.D., 2009. Chemistry and Biodiversity, 6 (5) pp. 591-684.

[DOI][WoS][Pmid][serval:BIB_5472451138C8]

The biochemistry of drug metabolism-an introduction: part 7. Intra-individual factors affecting drug metabolism.

Krämer S.D., Testa B., 2009. Chemistry & Biodiversity, 6 (10) pp. 1477-1660, table of contents.

[DOI][WoS][Pmid][serval:BIB_4D00FBC2C87F]

Utilisation «off label» des médicaments psychotropes (1/2)

Baumann Pierre, Voirol Pierre, 2009. PharmaJournal, 22 pp. 7-10.

[URN][serval:BIB_012C292BD483]

Utilisation «off label» des médicaments psychotropes (2/2)

Baumann Pierre, Voirol Pierre, 2009. PharmaJournal, 23 pp. 8-10.

[serval:BIB_8019366AB3C9]

2008

Care givers' assessment of the sedation drug use in an adult intensive care unit (ICU) : PT134

Voirol Pierre, Blanc Anne Laure, Delaloye Valia Humbert, Van Tulder Laurence, Gattlen Laurent, Chiolero René, Pannatier André, 2008. p. 730 dans Implementing Clinical Pharmacy in Community and Hospital Settings: Sharing the Experience : ESCP 36th European Symposium on Clinical Pharmacy, Pharmacy World and Science. Peer-reviewed.

[WoS][serval:BIB_5AD068339F4F]

In vitro evaluation of bronchodilator drug delivery by jet nebulization during pediatric mechanical ventilation.

Di Paolo E.R., Pannatier A., Cotting J., 2008. pp. 131-134 dans Yearbook Respiratory Care Clinics and Applied Technologies, Esquinas A..

[serval:BIB_25FA57F32EB7]

Pharmaceutical Applications on Columns Packed with Sub-2 m Particles

Russo R., Guillarme D., Nguyen D. T.- T., Bicchi C., Rudaz S., Veuthey J.-L., 2008. Journal of Chromatographic Science, 46 (3) pp. 199-208.

[URN][DOI][WoS][serval:BIB_44047B75C9AD]

The biochemistry of drug metabolism : an introduction : part 6, Inter-individual factors affecting drug metabolism.

Krämer S.D., Testa B., 2008. Chemistry and Biodiversity, 5 (12) pp. 2465-2578.

[DOI][WoS][Pmid][serval:BIB_8BC6A79346DB]

Vitamine D pour les nouveaux-nés et nourrissons : gouttes huileuses disponibles dans les pays proches de la Suisse.

Di Paolo E.R., Nydegger A., 2008. Paediatrica, 19 (3) pp. 75-76.

[serval:BIB_734DC942E9C8]

2007

Administration des médicaments chez les patients alimentés par sonde.

Michel C., Di Paolo E.R., Podislki G., Roulet M., Coti Bertrand P., 2007. Société Neuchâteloise de Médecine News., 55 pp. 19-23.

[serval:BIB_DFFEFF95BCA9]

Augmented myocardial methionine-enkephalin in a murine model of cardiac angiotensin II-overexpression.

van den Brink O.W., Delbridge L.M., Pedrazzini T., Rosenfeldt F.L., Pepe S., 2007. Journal of the Renin-Angiotensin-Aldosterone System, 8 (4) pp. 153-159. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_5BC91E87211D]

The development of a stable oral solution of captopril for paediatric patients

Berger-Gryllaki M., Podilsky G., Widmer N., Gloor S., Testa B., Pannatier A., 2007. European Journal of Hospital Pharmacy Science, 13 (3) pp. 67-72. Peer-reviewed.

[serval:BIB_819B7B222822]

2006

Is there really a survival benefit of SDD in burns?

Eggimann P., Chiolero R. L., Raffoul W., Voirol P., Berger M. M., 2006/08. Annals of Surgery, 244 (2) pp. 325-6; author reply 326-7.

[DOI][WoS][Pmid][serval:BIB_A9FDDB525551]

Emploi et toxicité de la paraffine liquide per os chez l'enfant.

Benkebil F., Di Paolo E.R., Roulet M., 2006. Paediatrica, 17 (5) pp. 23-25.

[serval:BIB_7920EE27CFA8]

Evaluation of Solid-Phase Microextraction Desorption Parameters for Fast GC Analysis of Cocaine in Coca Leaves

Ilias Y., Bieri S., Christen P., Veuthey J.-L., 2006. Journal of Chromatographic Science, 44 (7) pp. 394-398.

[URN][DOI][WoS][serval:BIB_E5AD0DBDDDC3]

Unlicensed and off-label drug use in a Swiss paediatric university hospital.

Di Paolo E.R., Stoetter H., Cotting J., Frey P., Gehri M., Beck-Popovic M., Tolsa J.F., Fanconi S., Pannatier A., 2006. Swiss Medical Weekly, 136 (13-14) pp. 218-222. Peer-reviewed.

[URN][WoS][Pmid][serval:BIB_CCC5CB681680]

Urgences psychiatriques: état d'agitation

Erb M., Herzog A., Widmer N., 2006. pp. 83-85 dans Gehri M., Laubscher B., Di Paolo E.R., Mazouni S.M. (eds.) Vade-Mecum de Pédiatrie chap. 8, BabyGuide.

[serval:BIB_2FE2D0235343]

Vade-Mecum de Pédiatrie, 3e édition.

Gehri M., Laubscher B., Di Paolo E.R., Mazouni S.M., 2006. 340, BabyGuide.

[serval:BIB_D16D11440334]

2005

A quand le remboursement de la ceftriaxone par les caisses-maladie lors de traitement ambulatoire chez l'enfant ? [Reimbursement policy for ambulatory treatment of pediatric infections with ceftriaxone]

Krahenbuhl J. D., Di Paolo E., Steiner S., Gehri M., 2005/07. Revue Médicale Suisse, 1 (27) pp. 1814-5.

[Pmid][serval:BIB_FFABA4B7FCD3]

In vitro evaluation of bronchodilator drug delivery by jet nebulization during pediatric mechanical ventilation.

Di Paolo E.R., Pannatier A., Cotting J., 2005/07. Pediatric Critical Care Medicine, 6 (4) pp. 462-469. Peer-reviewed.

[DOI][Pmid][serval:BIB_FF2A3C3AAFB2]

Formulation Optimization in a University Hospital: The Example of Pediatric Solutions of the ACE Inhibitor Captopril

Berger-Gryllaki M., Podilsky G., Widmer N., Gloor S., Testa B., Pannatier A., 2005/06/01. CHIMIA, 59 (6) p. 357. Peer-reviewed.

[DOI][WoS][serval:BIB_38439]

When fever, paracetamol? Theory and practice in a paediatric outpatient clinic

Gehri M., Guignard E., Djahnine S. R., Cotting J. Q., Yersin C., Di Paolo E. R., Krahenbuhl J. D., Pannatier A., 2005/06. Pharmacy World and Science, 27 (3) pp. 254-7.

[DOI][WoS][Pmid][serval:BIB_5133BF99FA20]

Auto-évaluation de la qualité d'un site Internet de pharmacie hospitalière

De Giorgi I., Widmer N., Cingria L., Wasilewski A.F., Fonzo-Christe C., Bonnabry P., 2005. dans GSASA-Kongress, Gesellschaft Schweizerischer Amt- und Spitalapotheker = Congrès annuel de la GSASA, Société suisse des pharmaciens de l'administration et des hôpitaux.

[serval:BIB_DD498138CB3E]

Stratégies destinées a optimiser l'utilisation des antibiotiques en réanimation [Strategies targeted at optimising antimicrobial therapy in critically ill patients]

Eggimann P., Oddo M., Voirol P., Zanetti G., Chioléro R., 2005. Revue médicale suisse, 1 (45) pp. 2928-32.

[Pmid][serval:BIB_EEA63AF97692]

Traitement de l’hypertension artérielle chez l’enfant : recommandations actuelles.

Cachat F., Di Paolo E.R., Sekarski N., 2005. Médecine et Enfance, 25 (10) pp. 629-638.

[serval:BIB_3A1C7C0E8C52]

2004

Impact of pharmacists' interventions on the pediatric discharge medication process.

Voirol P., Kayser S.R., Chang C.Y., Chang Q.L., Youmans S.L., 2004/10. The Annals of pharmacotherapy, 38 (10) pp. 1597-1602. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_8B4BD5225405]

Aérosolthérapie chez l'enfant et l'adolescent. Questions pratiques sur l’utilisation des nébuliseurs pneumatiques.

Di Paolo E.R., Gehri M., Quillet-Cotting J., Utiger A., 2004. GSASA-News, 18 (1) pp. 9-13.

[serval:BIB_5C285C33D831]

Développement d'une solution orale pédiatrique de captopril

Gryllaki-Berger M., Podilsky G., Widmer N., Gloor S., Pannatier A., 2004. dans 12es Journées Franco-Suisses de Pharmacie Hospitalière.

[serval:BIB_ED1FB16B5374]

Structure and interactions in chitosan hydrogels formed by complexation or aggregation for biomedical applications

Berger J, Reist M, Mayer J.M, Felt O, Gurny R, 2004/01. European Journal of Pharmaceutics and Biopharmaceutics, 57 (1) pp. 35-52.

[DOI][serval:BIB_8130BA487017]

Structure and interactions in covalently and ionically crosslinked chitosan hydrogels for biomedical applications.

Berger J., Reist M., Mayer J.M., Felt O., Peppas N.A., Gurny R., 2004/01. European journal of pharmaceutics and biopharmaceutics, 57 (1) pp. 19-34. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_5BF973130F92]

Traitement de l’hypertension artérielle chez l’enfant : recommandations actuelles.

Cachat F., Di Paolo E.R., Sekarski N., 2004. Paediatrica, 15 (5) pp. 26-34.

[serval:BIB_330A2E7150C2]

2003

Vade-Mecum de Pédiatrie, 2e édition

Mazouni S.M., Gehri M., Laubscher B., Di Paolo E.R., 2003/10. 244, CHUV.

[serval:BIB_248081C17413]

Aérosolthérapie chez l'enfant et l'adolescent: Nébulisation.

Di Paolo E.R., Gehri M., 2003. GSASA-News, 17 (4) pp. 106-110.

[serval:BIB_B943ED9891B3]

Évaluation d'une nouvelle méthode pour l'essai de stérilité des préparations pharmaceutiques

Widmer N., Pannatier A., Blanc D.S., 2003. dans GSASA-Kongress, Gesellschaft schweizerischer Amt- und Spitalapotheker = Congrès annuel de la GSASA, Société suisse des pharmaciens de l'administration et des hôpitaux.

[serval:BIB_66FD1137E9B6]

2002

In vitro biotransformation of the selective serotonin reuptake inhibitor citalopram, its enantiomers and demethylated metabolites by monoamine oxidase in rat and human brain preparations

Kosel M., Gnerre C., Voirol P., Amey M., Rochat B., Bouras C., Testa B., Baumann P., 2002. Molecular psychiatry, 7 (2) pp. 181-188. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_4F415C4F4FFF]

Very long half-life of paroxetine following intoxication in an extensive cytochrome P4502D6 metabolizer

Hilleret H., Voirol P., Bovier P., Giannakopoulos P., Zullino D., Baumann P., Giroud C., Rivier L., Eap C.B., 2002. Therapeutic drug monitoring, 24 (4) pp. 567-569. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_A9FB304D3F98]

2001

NMR and LC-MSn characterisation of two minor saponins from Ilex paraguariensis.

Martinet A., Ndjoko K., Terreaux C., Marston A., Hostettmann K., Schutz Y., 2001/02. Phytochemical Analysis, 12 (1) pp. 48-52.

[DOI][WoS][Pmid][serval:BIB_919EB1DC0F95]

Ondansetron for tardive dyskinesia

Zullino Daniele Fabio, Eap Chin-Bin, Voirol Pierre, 2001. American Journal of Psychiatry, 158 (4) pp. 657-658. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_A2DF1B800180]

Prescription des antidépresseurs chez la personne âgée : à propos de quelques spécificités

Eap Chin-Bin, Voirol Pierre, Baumann Pierre, Lima Carlos Augusto de Mendonça, 2001. dans La dépression : perspectives en psychiatrie de la personne âgée / réd. en chef Vincent Camus, Laurent Schmitt . - Paris : Serdi, 2001. - P. 131-150.

[serval:BIB_FC8462F74D4F]

Retrait d'un soluté pédiatrique buvable de digoxine: une décision peu judicieuse.

Di Paolo E.R., Curchod P., Radji-Djahnine S., Pannatier A., 2001. Journal Suisse de Pharmacie 23 pp. 787-789.

[serval:BIB_F9B9B096D28A]

Retrait du commerce d'un soluté pédiatrique buvable de digoxine : une décision peu judicieuse.

Di Paolo E.R., Curchod P., Radji-Djahnine S., Pannatier A, 2001. GSASA-News, 15 (4) pp. 70-72.

[serval:BIB_587CF47F7285]

2000

Evaluation of physicochemical incompatibilities during parenteral drug administration in a paediatric intensive care unit

Gikic M., Di Paolo E. R., Pannatier A., Cotting J., 2000/06. Pharmacy World and Science, 22 (3) pp. 88-91.

[DOI][WoS][Pmid][serval:BIB_5FB31455A472]

Monitoring thérapeutique des psychotropes et tests pharmacogénétiques en psychiatrie [Therapeutic monitoring of psychotropic drugs and pharmacogenetic tests in psychiatry]

Voirol P., Eap C.B., Baumann P., 2000. Revue médicale de la Suisse romande, 120 (2) pp. 99-104.

[Pmid][serval:BIB_E8B8D250E379]

Pharmakogenetische Charakterisierung - Pharmakogenetik in der Psychopharmakologie

Baumann Pierre, Kosel Markus, Voirol Pierre, 2000. dans Laboruntersuchungen in der psychiatrischen Routine / hrsg. von Markus Gastpar...[et al.] ; unter Mitarb. von M. Banger...[et al.]. - Stuttgart : Thieme , 2000. - P. 134-149.

[serval:BIB_2B5D4BF164C2]

Physicochemical aspects of nebulisation: comparison of five models of jet nebulisers

Di Paolo E.R., Cotting J., Pannatier A., 2000. European Hospital Pharmacy, 6 (3) pp. 83-87. Peer-reviewed.

[serval:BIB_A77C7B511765]

Serotonin syndrome after small doses of citalopram or sertraline

Voirol P., Hodel P.F., Zullino D., Baumann P., 2000. Journal of clinical psychopharmacology, 20 (6) pp. 713-4. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_D2CEC0FC6867]

1999

Thermogenic effects of commercially available plant preparations aimed at treating human obesity.

Martinet A., Hostettmann K., Schutz Y., 1999/10. Phytomedicine, 6 (4) pp. 231-238.

[DOI][WoS][Pmid][serval:BIB_27BA5C74D912]

Clinical pharmacokinetics of SSRIs

Baumann Pierre, Eap Chin B., Voirol Pierre, 1999. pp. 9-26 dans Stanford S. Clare (eds.) Selective serotonin reuptake inhibitors (SSRIs) - Past, present and future, R.G. Landes Company.

[serval:BIB_E84D15737812]

Ultraschnelle Metabolisierer. Grundlagen und klinische Bedeutung

Baumann Pierre, Eap Chin B., Steimer W., Kosel Markus, Voirol Pierre, 1999. Psychopharmakotherapie, 6 (2) pp. 62-64.

[serval:BIB_DF00B226A45B]

1998

An automated procedure for the determination of protein concentration in subcellular fractions.

Voirol P., Aubert A.C., Jonzier-Perey M., Baumann P., 1998/05/08. Clinica chimica acta; international journal of clinical chemistry, 273 (1) pp. 89-93. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_DE30A1CBD198]

2C-B: a new psychoactive phenylethylamine recently discovered in Ecstasy tablets sold on the Swiss black market.

Giroud C., Augsburger M., Rivier L., Mangin P., Sadeghipour F., Varesio E., Veuthey J.L., Kamalaprija P., 1998. Journal of Analytical Toxicology, 22 (5) pp. 345-354. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_ABC3FB8CEE6A]

1997

Ecstays et "raves" en Suisse Romande

Giroud C., Augsburger M., Sadeghipour F., Varesio E., Veuthey J. L., Rivier L., Mangin P, 1997. Toxicorama, 9 pp. 113-122.

[serval:BIB_26E82C3F0BB5]

Variation du pH, de l'osmolalité, de la concentration et de la température de solutions de salbutamol à 0.05% durant la nébulisation.

Di Paolo E.R., Cotting J., Pannatier A., 1997. GSASA-News, 11 (2) pp. 64-66.

[serval:BIB_9BFEC1300C17]

1996

La pharmacie hospitalière en Grande-Bretagne - Clinical Pharmacy Training Programme à l'Hope Hospital de Salford.

Di Paolo E.R., 1996. GSASA-News, 10 (1) pp. 8-10.

[serval:BIB_9326A22648BB]

1995

Commentaire sur les excipients de la Ph.H.VII

Di Paolo E.R., 1995. dans Le Stage, Le Cap.

[serval:BIB_D80F63B4AB00]

1990

Quantitative determination of particulate contamination in intravenous administration sets

Di Paolo E. R., Hirschi B., Pannatier A., 1990/10. Pharmaceutisch Weekblad. Scientific Edition, 12 (5) pp. 190-5.

[WoS][Pmid][serval:BIB_29750CE61B46]

1989

New chromonocoumarin (=6H, 7H-[1]Benzopyrano[4,3-b][1]benzopyran-6,7-dione) derivatives fromPolygala fruticosa BERG

Di Paolo E.R., Hamburger M.O., Stoeckli-Evans H., Rogers C., Hostettmann K., 1989/11/01. Helvetica Chimica Acta, 72 (7) pp. 1455-1462. Peer-reviewed.

[DOI][WoS][serval:BIB_345F6FE50DF0]

Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11

Contact
Annuaires

Informations légales
Plan du site
Edition